ABT 874 has promising activity in Crohn's disease

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1464, 2004-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infliximab promising in paediatric Crohn's disease

By  

Inpharma, Vol. 1, Iss. 1391, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Denileukin diftitox has promising activity in graft-versus-host disease (GVHD) following haematopoietic stem cell transplantation

By  

Inpharma, Vol. 1, Iss. 1458, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Epratuzumab has promising activity in aggressive NHL

By  

Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

MDX 018 shows promising activity in the treatment of an undisclosed autoimmune disease

By  

Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Plateletcrit: A sensitive biomarker for evaluating disease activity in Crohn's disease with low hs‐CRP

By  

Journal of Digestive Diseases, Vol. 16, Iss. 3, 2015-03 ,pp. : 118-124

John Wiley & Sons Inc

Access to resources Recommend Favorite